Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
All peptides

Dulaglutide

Also known as: Trulicity
FDA-Approved

Dulaglutide is a long-acting GLP-1 receptor agonist approved for type 2 diabetes and CV risk reduction.

Buy Dulaglutide on American Peptides

Affiliate link — we may earn a commission at no extra cost to you.

Overview

Dulaglutide is a long-acting GLP-1 receptor agonist approved for type 2 diabetes and CV risk reduction.

FDA Approval Status

Approved by the FDA for at least one medical indication (see approved uses below).

Mechanism of Action

GLP-1 receptor agonism.

Current Research

REWIND trial showed CV benefits.
Research strength: Strong

Potential Medical Uses

  • Type 2 diabetes
  • CV risk reduction in T2D

Potential Benefits

  • Weekly dosing
  • A1C reduction
  • CV benefit

Known Side Effects

  • GI upset
  • Injection reactions

Contraindications

  • MTC/MEN 2 history

Drug Interactions

  • Insulin/sulfonylureas

Administration Methods

  • Subcutaneous injection weekly

Half-life

~5 days

Reconstitution

Prefilled pen.

Storage & Handling

Refrigerate.

References & Sources

Frequently Asked Questions

Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.